Interim Report January-September 2023
Report and presentation: https://nanoform.com/en/nanoform-q3-2023-nanoformed-blockbuster-drug-enters-clinic-and-another-nanoformed-drug-received-fda-orphan-designation/
Webcast: https://ir.financialhearings.com/nanoform-q3-report-2023
Telephone conference: https://conference.financialhearings.com/teleconference/?id=5005133